Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Economic Burden Associated With Nintedanib Non-adherence Among Medicare Beneficiaries With IPF

NCT05870956 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT05870956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05870956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Economic Burden Associated With Nintedanib Non-adherence Among Medicare Beneficiaries With IPF
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
May 16, 2023
Completion date
June 30, 2023
Enrollment
1,798 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic pulmonary fibrosis